Pay in 4 interest-free payments of $5.15 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Scale weight alone fails to distinguish between fat and muscle changes
Visit ClinicalTrials.gov to see all ongoing trials
Category: Immune Support, Energy, Anti-Aging Note: A representative will reach out to you directly to schedule and confirm your appointment
NCT06015893 Semaglutide Therapy for Alcohol Reduction (STAR) Status: Recruiting This study will test the safety/tolerability and early efficacy of subcutaneous (s.c.) semaglutide at the dose of 2.4 mg/week or maximum tolerated dose (MTD) as a potential new treatment for alcohol use disorder (AUD)
Pre-clinical models confirm it: rats dosed with liposomal GSH showed 40% less paw oedema and lower rheumatoid factor levels, mirroring the potential in humans
US$ 25.03
US$ 21.68
US$ 20.29
US$ 25.10
US$ 28.75
